Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessStocksAurobindo Pharma up 2%, gets USFDA approval for Meropenem Injection

    Aurobindo Pharma up 2%, gets USFDA approval for Meropenem Injection

    March 28, 2017 / 11:03 IST

    Share price of Aurobindo Pharma rose 2 percent intraday Tuesday on USFDA approval for Meropenem Injection.

    The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Meropenem Injection 500 mg/ vial and 1g/vial.

    Meropenem injection is a generic equivalent of AstraZeneca Pharmaceuticals' Merrem injection.

    The product will be launched in April 2017.

    According to IMS, the approved product has an estimated market size of USD 118 million for the 12 months ending January 2017.

    At 10:58 hrs Aurobindo Pharma was quoting at Rs 679.90, up Rs 9.60, or 1.43 percent on the BSE.

    Posted by Rakesh Patil
    first published: Mar 28, 2017 11:03 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347